Proposal for a bipolar-stimulant spectrum: Temperament, diagnostic validation and therapeutic outcomes with mood stabilizers

Journal of Affective Disorders

Volumn 85, Issue 1-2, 2005, Pages 217-230

  Camacho, Alvaro ^a   Akiskal, Hagop S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Affective temperaments; Alcohol; Bipolar spectrum; Dual diagnosis; Stimulants

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; GABAPENTIN; LITHIUM; MOOD STABILIZER; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; PROPRANOLOL; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRAZODONE; VALPROIC ACID;

ADDICTION; ADULT; ARTICLE; BIPOLAR DISORDER; BIPOLAR II DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; CYCLOTHYMIA; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DRUG ABUSE; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPOMANIA; IRRITABILITY; LIBIDO DISORDER; LOW DRUG DOSE; MALE; MOOD DISORDER; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; TEMPERAMENT; TREATMENT OUTCOME; TREMOR; VALIDATION PROCESS; WEIGHT GAIN; WITHDRAWAL SYNDROME;

EID: 15244347799     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2003.10.014     Document Type: Article

References (47)

1. Akiskal H.S. The distinctive mixed states of bipolar I, II and III. Clin. Neuropharmacol. 15:(Suppl. 1A):1992;632-633
2. Akiskal H.S., Mallya G. Criteria for the "soft" bipolar spectrum: treatment implications. Psychopharmacol. Bull. 23:1987;68-73
3. Akiskal H.S., Pinto O. The evolving bipolar spectrum: prototypes I, II, III, IV. Psychiatr. Clin. North Am. 22:1999;517-534
4. Akiskal H.S., Djenderedjian A.H., Rosenthal R.H., Khani M.K. Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group. Am. J. Psychiatry. 134:1977;1227-1233
5. Akiskal H.S., Khani M.K., Scott-Strauss A. Cyclothymic temperamental disorders. Psychiatr. Clin. North Am. 2:1979;527-554
6. Akiskal H.S., Downs J., Jordan P., Watson S., Daugherty D., Pruitt D.B. Affective disorders in the referred children and younger siblings of manic-depressives: mode of onset and prospective course. Arch. Gen. Psychiatry. 42:1985;996-1003
7. Akiskal H.S., Maser J.D., Zeller P., Endicott J., Coryell W., Keller M., Warshaw M., Clayton P., Goodwin F.K. Switching from "unipolar" to bipolar II: an 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch. Gen. Psychiatry. 52:1995;114-123
8. Akiskal H.S., Placidi G.F., Signoretta S., Liguori A., Gervasi R., Maremmani I., Mallya G., Puzantian V.R. TEMPS-I: delineating the most discriminant traits of cyclothymic, depressive, irritable and hyperthymic temperaments in a nonpatient population. J. Affect. Disord. 51:1998;7-19
9. Akiskal H.S., Hantouche E.G., Allilaire J.-F. Bipolar II with and without cyclothymic temperament: "dark" and "sunny" expressions of soft bipolarity. J. Affect. Disord. 73:2003;49-57
10. Akiskal H.S., Hantouche E.G., Allilaire J.F., Sechter D., Bourgeois M.L., Azorin J.M., Chatenet-Duchene L., Lancrenon S. Validating antidepressant- associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II). J. Affect. Disord. 73:2003;65-74
11. Akiskal H.S., Mendlowicz M.V., Jean-Louis G., Rapaport M.H., Kelsoe J.R., Gillin J.C., Smith T.L. TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament. J. Affect. Disord. 85:2005;45-52
12. Akiskal H.S., Akiskal K.K., Haykal R.F., Manning J.S., Connor P.D. TEMPS-A: progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire. J. Affect. Disord. 85:2005;3-16
13. Brady K.T., Sonne S.C. The relationship between substance abuse and bipolar disorder. J. Clin. Psychol. 56:(Suppl. 3):1995;19-24
14. Brady K.T., Sonne S.C., Anton R., Ballenger J.C. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J. Clin. Psychol. 56:1995;118-121
15. Brady K.T., Sonne S.C., Malcolm R.J., Randall C.L., Dansky B.S., Simpson K., Roberts J.S., Brodino M. Carbamazepine in cocaine dependent individuals with affective disorder. Exp. Clin. Psychopharmacol. 10:2002;276-285
16. Brown S.E., Nejtek V.A., Perantie D.A., Bobadilla L. Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord. 4:2002;406-411
17. Brown S.E., Nejtek V.A., Perantie D.C., Orsulak P.J., Bobadilla L. Lamotrigine in patients with bipolar disorder and cocaine dependence. J. Clin. Psychol. 64:2003;197-201
18. Calabrese J.R., Shelton M.D., Bowden C.L., Rapport D.J., Suppes T., Shirley E.R., Kimmel S.E., Caban S.J. Bipolar rapid cycling: focus on depression as its hallmark. J. Clin. Psychiatry. 62:(Suppl. 14):2001;34-41
19. Cassidy F. Substance abuse in bipolar disorder. Bipolar Disord. 3:2001;181-188
20. Chengappa K.N., Levine J., Gershon S., Kupfer D.J. Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry. Bipolar Disord. 2:(3Pt. 1):2000;191-195
21. Compton W.M., Cottler L.B., Phelps D.L., Ben Abdallah A., Spitznagel E.L. Psychiatric disorders among drug dependent subjects: are they primary or secondary. Am. J. Addict. 9:2000;126-134
22. Gawin F.H., Kleber H.D., Byck R., Rounsaville B.J., Kosten T.R., Jatlow P.I., Morgan C. Desipramine facilitation of initial cocaine abstinence. Arch. Gen. Psychiatry. 46:1989;117-121
23. Khantzian E.J. Self medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am. J. Psychiatry. 142:1985;1259-1264
24. Khantizian E.J. The self medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv. Rev. Psychiatry. 4:1997;231-244
25. Lemere F., Smith J.W. Hypomanic personality trait in cocaine addiction. Br. J. Addict. 85:1990;575-576
26. Majewska M.D. Cocaine addiction as a neurological disorder: implications for treatment. NIDA Res. Monogr. 163:1996;1-26
27. Maremmani I., Capone M.R., Aglietti M., Castrogiovanni P. Heroin dependence and bipolar disorders. New Trends Exp. Clin. Psychiatry. X:1994;179-182
28. Maremmani I., Pacini M., Lubrano S., Lovrecic M., Perugi G. Dual diagnosis heroin addicts. The clinical and therapeutic aspects. Heroin Addict. Rel. Clin. Probl. 5:2003;7-98
29. Margolin A., Avants S.K., DePhilippis D., Kosten T.R. A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients. Am. J. Drug Alcohol Abuse. 24:1998;85-101
30. Oliveto A., McCance-Kantz F.E., Singha A., Petrakis I., Hameedi F., Kosten T.R. Effects of cocaine prior to and during bupropion treatment maintenance in cocaine-abusing volunteers. Drug Alcohol Depend. 63:2001;155-167
31. Perugi G., Frare F., Madaro D., Maremmani I., Akiskal H.S. Alcohol abuse in social phobic patients: is there a bipolar connection? J. Affect. Disord. 68:2002;33-39
32. Pinto O., Akiskal H.S. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder. J. Affect. Disord. 51:1998;333-343
33. Placidi G.F., Signoretta S., Liguori A., Gervasi R., Maremmani I., Akiskal H.S. The semi-structured affective temperament Interview (TEMPS-I): reliability and psychometric properties in 1010 14-26 year students. J. Affect. Disord. 47:1998;1-10
34. Ranaldi R., Poeggel K. Baclofen decreases methamphetamine self-administration in rats. Neuroreport. 13:2002;1107-1110
35. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Cathchment Area (ECA) Study. JAMA. 264:1990;2511-2518
36. Rosenblum A., Fallon B., Magura S., Handelsman L., Foote J., Bernstein D. The autonomy of mood disorders among cocaine-using methadone patients. Am. J. Drug Alcohol Abuse. 25:1999;67-80
37. Rosethal R.N., Westriech L. Treatment of persons with dual diagnosis of substance use disorder and other psychological problems. McCrady B.S., Epstein E.E. Addictions: A Comprehensive Textbook. 1999;439-476 Oxford Press, New York
38. Sachs G.S. Decision tree for the treatment of bipolar disorder. J. Clin. Psychiatry. 64:2003;35-40
39. Salloum I.M., Thase M.E. Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord. 2:2000;268-280
40. Silverstone P.H., Pukhovsky A., Rotzinger S. Lithium does not attenuate the effects of D-amphetamine in healthy volunteers. Psychiatry Res. 79:1998;219-226
41. Sutor B., Tinsley J.A., Morse R.M. Management of patients with bipolar mood disorder and substance dependence. J. Addict. Disord. 18:1999;83-93
42. Tohen M., Greenfield S.F., Weiss R.D., Zarate C.A. Jr., Vagge L.M. The effect of comorbid substance use disorders on the course of bipolar disorder: a review. Harv. Rev. Psychiatry. 6:1998;133-141
43. Van Kammen D.P., Murphy D.L. Attenuation of the euphoriant and activating effects of D- and L-amphetamine by lithium carbonate treatment. Psychopharmacologia. 44:1975;215-224
44. Weiss R.D. Relapse to cocaine abuse after initiating desipramine treatment. JAMA. 260:1988;2545-2546
45. Weiss R.D., Mirin S.M., Griffin M.L., Michael J.L. Psychopathology in cocaine abusers. Changing trends. J. Nerv. Ment. Dis. 176:1998;719-725
46. Winokur G., Turvey C., Akiskal H., Coryell W., Solomon D., Leon A., Mueller T., Endicott J., Maser J., Keller M. Alcoholism and drug abuse in three groups - bipolar I, unipolars and their acquaintances. J. Affect. Disord. 50:1998;81-89
47. Wu L.T., Kouzis A.C., Leaf P.J. Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the National Comorbidity Survey. Am. J. Psychiatry. 156:1999;1230-1236